Search Results

You are looking at 1 - 10 of 205 items for :

  • site-directed mutagenesis x
  • Refine by Access: All content x
Clear All
Open access

Feng Zhang, Qi Xiong, Hu Tao, Yang Liu, Nian Zhang, Xiao-Feng Li, Xiao-Jun Suo, Qian-Ping Yang, and Ming-Xin Chen

-expression of C/EBPα downregulated ACOX1 luciferase activity. (B) The schematic diagram of site-directed mutagenesis in the predicted C/EBPα binding sites in the ACOX1 promoter. (C and D) A series of mutants of three C/EBPα binding sites were constructed and

Free access

Thomas Ohnesorg, Brigitte Keller, Martin Hrabé de Angelis, and Jerzy Adamski

, The Netherlands) was used. All constructs were confirmed by sequencing. Site-directed mutagenesis Mutant constructs of TF-binding sites were generated using the QuikChange Site-Directed Mutagenesis (Stratagene

Free access

Anne-Marie O’Carroll, Stephen J Lolait, and Gillian M Howell

.3) buffer and visualized by autoradiography by exposure to Kodak XAR film at −80 °C with intensifying screens. Site-directed mutagenesis The rat APJR 5′-flanking region 1 kb construct, bp −966 to −7 subcloned into the pGL3

Free access

Kun Chen, Ji-Dan Zhou, Feng Zhang, Fang Zhang, Rui-Rui Zhang, Meng-Si Zhan, Xiao-Yin Tang, Bing Deng, Ming-Gang Lei, and Yuan-Zhu Xiong

:// ) ( Fig. 2 A). Further analysis of a putative C/EBPβ binding site suggested that it is highly conserved in human, mouse and pig ( Fig. 2 B). Site-directed mutagenesis was performed using a WT pGL3-P5 construct as a template, aiming to functionally

Free access

Nikolaos Volakakis, Michal Malewicz, Banafsheh Kadkhodai, Thomas Perlmann, and Gerard Benoit

-activators and utilizes an alternative LBD region for transcriptional activation. In this study, we have used structural modeling to identify an alternative co-activator interaction surface in the Nurr1 LBD. Combined with site-directed mutagenesis, these studies

Free access

Raquel Tobar-Rubin, Dahlia Sultan, Daniela Janevska, Kyle Turcic, Julie Carroll, Laura Ooms, and Robin Pals-Rylaarsdam

(Guthrie cDNA Resource Center) was subjected to site-directed mutagenesis using the Stratagene QuickChange II XL site-directed mutagenesis kit. Mutagenic primers introduced or eliminated unique restriction sites (silent mutations) into the cDNA encoding

Free access

George G J M Kuiper, Willem Klootwijk, and Theo J Visser

). After the D1 cDNA cloning ( Berry et al. 1991 a ), site-directed mutagenesis and deletion analysis have identified several functional regions of the D1 protein ( Berry et al. 1991 b , 1992 , Toyoda et al. 1995 a , b , 1997 , Leonard et al

Free access

Bassam El-Asmar, Xavier C Giner, and Jacques J Tremblay

promoter constructs (deletions, mutagenesis) and for electromobility shift assays Nur77 promoter constructs (added cloning sites are italicized: Kpn 1 in reverse primer and Bam HI in forward primers)  Common reverse primer CT GGTACC GCGTGCGCTCTGCAATCCTTC

Free access

See-Tong Pang, Wen-Chi Hsieh, Cheng-Keng Chuang, Chun-Hsiang Chao, Wen-Hui Weng, and Horng-Heng Juang

with 1:1000 diluted monoclonal TXNIP antiserum (JY2; MBL International Corp., Woburn, MA, USA) or 1:1000 diluted anti β-actin antiserum (C11, Santa Cruz Biotechnology, Santa Cruz, CA, USA). Reporter vector constructs and site-directed mutagenesis The

Free access

Jan Wilde, Maria Erdmann, Michael Mertens, Gabriele Eiselt, and Martin Schmidt

2001 ). For site-directed mutagenesis of putative transcription factor-binding sites, the QuikChange II XL Kit (Stratagene, La Jolla, CA, USA) was used according to the manufacturer's recommendations. The sequences of all the constructs were verified by